Kea Insight / Analyst Relations

The Value of Analyst Research Starts Before the Reprint

By Bram Weerts

Analyst influence on buying decisions rarely begins with a marketing campaign. It may begin when a buyer reads an evaluation through their own research subscription, or asks an analyst which suppliers merit consideration. The vendor does not see either interaction.

Yet when companies report the value of Analyst Relations, the easiest number to produce is often pipeline associated with a licensed research reprint. That is a legitimate measure. It is not the whole commercial return.

There are three different outcomes to separate: inclusion in research buyers already use, the results of promoting licensed research, and the independent advice analysts give about vendors that may not appear in an evaluation at all.

Research inclusion has value before a campaign exists

Imagine a software company qualifies for a Gartner Magic Quadrant after several years of product development, customer growth and analyst engagement. It is now assessed alongside established competitors in a report covering its market.

That is an achievement in its own right. The analysts have applied their stated inclusion criteria and considered the company within a defined competitive set. Inclusion is not a recommendation, and the position within an evaluation matters. But the company is now visible in research that relevant buyers may consult when deciding where to start.

The same principle applies to a Forrester Wave or IDC MarketScape. A buyer with access can find the assessment without visiting the vendor’s website or responding to a campaign. They may put the company on a longer list, investigate a capability or decide it is not suitable. Each is an independent buyer decision informed by research.

The vendor may never know the report played a part. It has no download form on the buyer’s subscription portal and no campaign code attached to a private research session. That does not reduce the significance of being considered.

The buying research is not always a Magic Quadrant

Too many discussions about analyst evaluations stop with Gartner, Forrester and IDC. They matter greatly in many technology markets. They are not the complete research landscape, particularly in outsourcing, IT services and enterprise sourcing.

Everest Group’s PEAK Matrix assesses technology and services providers against market impact and delivery-related capabilities. ISG Provider Lens compares providers in defined service markets and regions; ISG also describes how its advisers use this research when working with enterprise clients. These are not peripheral publications for a provider selling managed services or transformation work.

Nucleus Research’s Technology Value Matrix evaluates technology on usability and functionality. QKS Group’s SPARK Matrix assesses Technology Excellence and Customer Impact. NelsonHall’s NEAT and Avasant’s RadarView are also relevant in services markets, depending on the buying requirement.

No single framework covers every relevant provider or every enterprise buying process. Methodology, market scope, geography and intended audience vary. An AR programme should know which evaluations its buyers actually use, rather than treating the largest three firm names as a universal priority list.

A reprint measures distribution, not the whole return

After an evaluation is published, Marketing may license it for external distribution. The company can then direct prospects to an authorised copy, build a campaign around the research and record responses in its CRM.

That has real uses. It gives Sales an independent assessment to discuss, subject to the licence and the research firm’s rules. It also provides measurable activity: visits, downloads, engaged accounts, opportunities created or supported, and subsequent sales outcomes.

Reprint rights are not automatic. Gartner, for example, requires an appropriate licence or approval for external use of its research. The cost and permissions differ between firms, reports and usage arrangements.

But a reprint campaign is a second commercial activity. It distributes research the analysts have already produced. The original evaluation remains available to readers with their own entitlement, whether or not the vendor buys marketing rights.

A campaign that becomes associated with €1 million in pipeline has reported a useful outcome. It has not proved that €1 million of pipeline would otherwise not exist. And it has captured nothing about buyers who discovered the company through their own research access.

What happens when the vendor is not in the report?

Some of the most consequential analyst conversations concern companies that are not in a major evaluation. A newer provider may sit below a revenue threshold, serve a narrower segment or operate in a market for which the firm has no suitable comparison report.

That does not prevent an enterprise buyer from asking about it. Procurement may want an independent view before approving a smaller supplier. A technical team may prefer that supplier but need help explaining the decision to executives.

We have seen this in enterprise software purchasing. In one case, the buyer’s technical team had a strong reason to replace an incumbent with a smaller provider. Procurement still wanted independent confirmation that the provider was credible and capable of supporting the business. Discussions with research firms were part of the decision process. The supplier’s longstanding engagement with relevant analysts meant they were familiar with its capabilities.

The commercial value was not a downloaded report. It was confidence to examine a provider that did not have the incumbent’s size or history. We cannot claim that analyst advice alone won the contract; product evidence and the buyer’s own tests mattered too. We can say that independent research input played a part in the buying decision.

Nor should a vendor try to discover what an analyst told a particular client in a confidential inquiry. The question for AR is whether the relevant analysts understand the supplier accurately and can make their own assessment when asked.

Ask buyers where their shortlist came from

This influence is harder to track than a form submission. It is not necessarily impossible to document.

Start with the questions the account team is already in a position to ask: How did you hear about us? What put us on your shortlist? Which external sources helped you compare providers? Ask early enough to learn about research that shaped the search, not just material used after the buyer had chosen whom to contact.

Do not start by asking whether Gartner recommended the company. Buyers may have used Everest Group, ISG, Nucleus Research, a specialist analyst, a consultant or no research at all. A leading question makes the result less useful.

Record what the buyer actually says. Name the firm or report only when it is known. Distinguish published research from a direct advisory conversation, and a buyer’s account from a salesperson’s interpretation. Bring that information back to AR, where it can change analyst priorities and the evidence supplied in briefings.

It belongs in post-deal reviews too. The process, including the questions to use and their limitations, is covered in our Insight Ask Buyers Where Analysts Made a Difference.

Report the evidence at the right level

Do not merge research inclusion, campaign performance and buyer-reported advice into a single figure labelled ‘AR-generated revenue’. They answer different questions.

Research visibility: inclusion in a relevant evaluation, with its scope, position and limitations clearly stated.
Research activation: results associated with licensed distribution, including cost, engagement, supported opportunities and pipeline.
Buyer-reported influence: documented instances where buyers say research or advice affected discovery, shortlist formation, evaluation criteria or confidence.

For buyer feedback, keep the sample visible. If 20 buyers were asked and four independently said analyst advice affected their shortlist, report four of 20, not an invented industry influence percentage. Explain how the accounts were selected and what the respondents actually confirmed.

Even a disciplined programme cannot see the buyers who never contact the company. That is an unavoidable limit, not an excuse to count every enterprise contract as an AR win.

The commercial case is broader than the campaign

An expensive research reprint may be a sound marketing decision. It may also be unnecessary for a company whose immediate priority is simply to become known and understood among analysts advising its buyers.

A well-run AR programme gives those analysts current evidence, relevant customer experience and an accurate account of what has changed. It does not buy agreement or guarantee a place on a shortlist. Its job is to make informed independent consideration possible.

So measure the reprint campaign. Celebrate relevant research inclusion. But ask Sales why buyers approached the company before the campaign reached them.

The most useful AR evidence may be a customer saying: “We asked an analyst about you. That’s why we took a closer look.”

That is worth recording, even when no marketing dashboard saw it happen.

Related Kea Insights

Put this into practice

Make analyst understanding part of the buying decision.

Kea helps technology vendors build analyst mindshare, prepare the evidence buyers need, and learn where independent research influences commercial decisions.

Explore AR-as-a-Service

Not sure where to start? Take the eight-question AR Readiness Check.